Q Lu, K Lee, F Xu, W Xia, Q Zheng, R Hong… - Cancer …, 2020 - europepmc.org
Background Real-world data of the CM regimen [cyclophosphamide (CTX) plus methotrexate (MTX)] in metronomic pattern for advanced breast cancer is limited to small …
Q Lu, L Kaping, F Xu, W Xia, Q Zheng… - Cancer …, 2020 - search.proquest.com
Background Real‐world data of the CM regimen [cyclophosphamide (CTX) plus methotrexate (MTX)] in metronomic pattern for advanced breast cancer is limited to small …
Q Lu, K Lee, F Xu, W Xia, Q Zheng, R Hong… - Cancer …, 2020 - ncbi.nlm.nih.gov
Background Real‐world data of the CM regimen [cyclophosphamide (CTX) plus methotrexate (MTX)] in metronomic pattern for advanced breast cancer is limited to small …
Q Lu, K Lee, F Xu, W Xia, Q Zheng… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Real-world data of the CM regimen [cyclophosphamide (CTX) plus methotrexate (MTX)] in metronomic pattern for advanced breast cancer is limited to small …